Refinitiv Newscasts - BVTV: Pricey Danish enzymes

Alk-Abello A/S

12/12/2022 15:30

Click the following link to watch video: https://share.newscasts.refinitiv.com/link?entryId=1_vi18qhf9&referenceId=1_vi18qhf9&pageId=RefinitivNewscasts
Source: Reuters

Description: Novozymes will absorb smaller domestic rival Chr. Hansen. The 38%
premium dwarfs expected synergies. And Novo Holdings, the main shareholder of
both groups, will retain majority voting rights. Novozymes investors may be
paying too much for future growth, Pierre Briancon says.
Short Link: https://refini.tv/3UP7DZI

Video Transcript:

Verified transcript not available